Gary T. Shearman - Concepedia

Author

Gary T. Shearman

Also Known As

, G Shearman, G T Shearman, G. Shearman, G. T. Shearman, G.T. Shearman, GARY T. SHEARMAN, Gary Shearman, Gary T. Shearman, Gary T. Shearman

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Rhode Island Max Planck Institute of Psychiatry Texas College Mayo Clinic in Arizona University of California San Diego

About

Gary T. Shearman is an author at University of Rhode Island specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	34	1.4K
2	Social Sciences	16	18	762
3	Health Sciences	11	11	483
4	Engineering	1	1	13
5	Allergy	1	1	16

Gary T. Shearman

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats R Przewłocki, Gary T. Shearman, A. Herz Neuropeptides Intrathecal InjectionOpioid EpidemicNeuropeptidesHealth SciencesAddiction	1983	140
The Effects of Dizocilpine Maleate (MK-801), an Antagonist of the <i>N</i>-Methyl-D-Aspartate Receptor, on Neurologic Recovery and Histopathology following Complete Cerebral Ischemia in Primates William L. Lanier, William J. Perkins, Bente R. Karlsson, Journal of Cerebral Blood Flow & Metabolism	1990	100
Discriminative stimulus properties of ?-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors David Stephens, Gary T. Shearman, W. Kehr Psychopharmacology Discriminative Stimulus PropertiesBehavioral NeuroscienceMedicineInverse AgonistsPsychotropic Medication	1984	94
Analgesic effects of μ-, δ- and κ-opiate agonists and, in particular, dynorphin at the spinal level Ryszard Przewłocki, L. Stala, M. Greczek, Life Sciences κ-Opiate AgonistsHealth SciencesPain MedicineMedicinePostoperative Pain Management	1983	83
Evidence that gaba mechanisms mediate the anxiolytic action of benzodiazepines: A study with valproic acid H. Lal, Gary T. Shearman, Sharmonay Fielding, Neuropharmacology Psychotropic MedicationPsychopharmacologyPharmacotherapyGaba MechanismsExperimental Pharmacology	1980	78
Discriminative stimulus properties of pentylenetetrazol and bemegride: Some generalization and antagonism tests Gary T. Shearman, Harbans Lal Psychopharmacology Discriminative Stimulus PropertiesBehavioral NeuroscienceMedicineBehavioural PharmacologyBehavioral Pharmacology	1979	77
MK-801, an Excitatory Amino Acid Antagonist, Does Not Improve Neurologic Outcome following Cardiac Arrest in Cats Jerry E. Fleischer, Akio Tateishi, John C. Drummond, Journal of Cerebral Blood Flow & Metabolism	1989	67
The noncompetitive N-methyl-d-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits Mark S. Scheller, Mark H. Zornow, Jerry E. Fleischer, Neuropharmacology MedicinePhysiologyVolatile Anesthetic RequirementsAnesthetic MechanismNeuropharmacology	1989	64
Generalization and antagonism studies with convulsant, GABAergic and anticonvulsant drugs in rats trained to discriminate pentylenetetrazol from saline Gary T. Shearman, H. Lal Neuropharmacology Anticonvulsant DrugsBehavioral NeuroscienceMedicineBehavioural PharmacologyPsychopharmacology	1980	63
Evaluation of the glutamate antagonist dizocilipine maleate (MK-801) on neurologic outcome in a canine model of complete cerebral ischemia: correlation with hippocampal histopathology John D. Michenfelder, William L. Lanier, Bernd W. Scheithauer, Brain Research Social SciencesCerebral Vascular RegulationCanine ModelBrain InjuryNeurology	1989	56

Page 1